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Abstract Research on the bioavailability of water from
thickened ﬂuids has recently been published and it con-
cluded that the addition of certain thickening agents
(namely, modiﬁed maize starch, guar gum, and xanthan
gum) does not signiﬁcantly alter the absorption of water
from the healthy, mature human gut. Using xanthan gum as
an example, our ‘‘proof of concept’’ study describes a
simple, accurate, and noninvasive alternative to the meth-
odology used in that ﬁrst study, and involves the mea-
surement and comparison of the dilution space ratios of the
isotopes
2H and
18O and subsequent calculation of total
body water. Our method involves the ingestion of a
thickening agent labeled with
2H 1 day after ingestion of
18O. Analyses are based on the isotopic enrichment of urine
samples collected prior to the administration of each iso-
tope, and daily urine samples collected for 15 days post-
dosing. We urge that further research is needed to evaluate
the impact of various thickening agents on the bioavail-
ability of water from the developing gut and in cases of gut
pathology and recommend our methodology.
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Health professionals working in feeding/swallowing clinics
frequently recommend the use of thickening agents for
therapeutic purposes with both adult and pediatric case-
loads. Within the pediatric population, thickened ﬂuids are
often recommended by health professionals for two main
groups of patients: (1) children at risk of aspirating regular
(i.e., thin) ﬂuids into their airway, and (2) those children
who display regurgitation. The rationale behind thickening
ﬂuids is to assist with the safe swallowing of ﬂuids and/or
to reduce the regurgitation of feeds, thereby optimising
nutritional status and, it is assumed, preventing dehydra-
tion. However, little information is currently available
regarding the bioavailability of water from thickened
ﬂuids.
The issue of hydration is of particular importance when
managing pediatric patients. Fluid, in the form of infant
formula or breast milk, is an infant’s sole source of nutri-
tion until approximately 6 months, and a large part of their
diet until approximately 12 months. Therefore, any
reduction in the availability of water from ﬂuid feeds could
not be compensated for by water from solid food types. In
addition, due to the nature of their disorder, patients with
dysphagia and/or regurgitation may have more difﬁculty
consuming their daily ﬂuid intake requirements than the
general population [1]. Any irreversible binding of water
by thickening agents would have the potential to exacer-
bate this problem by limiting the water available from any
ﬂuid that is consumed. This would have the potential to
lead to dehydration and associated problems. Furthermore,
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feeding problems in this population worse, as constipation,
a common symptom of dehydration, may result in reduced
hunger, irritability and behavioral issues [2].
Sharpe et al. [3] recently produced the ﬁrst (and, to our
knowledge, only) published research on the issue of bio-
availability of water from thickened ﬂuids. Sharpe et al. [3]
developed a novel method for testing the bioavailability of
water from thickened ﬂuids. Speciﬁcally, the investigators
provided participants with repeated test samples of water
containing bromide and deuterium oxide (
2H2O) mixed
with various thickening agents (namely, modiﬁed maize
starch, guar gum, and xanthan gum) for consumption.
Participants were required to give a 5-ml blood sample
before being dosed with each test ﬂuid and at 240 min
postdosing. In addition, saliva samples were taken before
dosing and at 10, 20, 30, 45, 60, 90, 120, and 240 min
postdosing. The investigators also tested participants’
bioelectrical impedance pre- and postconsumption of
thickened ﬂuids. They concluded that the addition of cer-
tain commonly used thickening agents did not signiﬁcantly
alter the absorption rate of water from the healthy, mature
human gut.
This article is a ‘‘proof of concept’’ study that details a
simple method for assessing the bioavailability of water
when mixed with ﬂuid thickeners that is more accurate and
less invasive than that proposed by Sharpe et al. [3]. For the
purpose of illustrating our method, we have used a ﬂuid
thickened with xanthan gum and administered to a single
subject as a case study.
Methods
Procedure
Total body water (TBW) was measured on two consecutive
days using stable, nonradioactive, nontoxic isotopes. For
the ﬁrst measurement of TBW, the participant was given an
oral dose of an isotope of oxygen (O
18), in the form of
water (H2
18O). The subject consumed 1.5 g/kg body weight
of 4% H2
18O via a syringe to minimise residue. The dose
consumed was recorded to the nearest 10 mg. A single
urine sample was obtained before the dose and subsequent
urine samples were collected 4–6 h postdose and then once
every 24 h (approximately) for the following 15 days. The
subject recorded the time each urine sample was collected.
At the same time the following day, TBW was again
measured using an isotope of hydrogen (
2H) in the form of
water (
2H2O, deuterium oxide). The subject consumed via
a syringe 0.05 g/kg body weight of 99.9% deuterium oxide
mixed into a sample of 50 ml tap water plus a xanthan gum
ﬂuid thickener (EasyThick, Flavour Creations). Xanthan
gum was chosen for the purpose of illustrating our novel
stable isotope method because it is a commonly used ﬂuid
thickener, and it was one of thickening agents tested by
Sharpe et al. [3]. Other thickening agents may be substi-
tuted for labeling with
2H, and the
2H could be added to
sample ﬂuids other than tap water (e.g., juice, cordial, milk,
infant formula). The solution was thickened according to
the manufacturer’s instructions to produce a solution
thickened to full (pudding) thick. The dose was recorded to
the nearest 10 mg. A single urine sample was obtained
before the dose and 4–6 h postdose. The daily urine sam-
ples collected for
18O analysis were also used for
2H
analysis. All urine samples were frozen until analysis. It
was not necessary to place predose restrictions on the
participant with respect to food or drink consumption on
either of the testing days, as this method yields an average
result from the collection of multiple urine samples over a
2-week period. In addition, the isotopic enrichment of each
postdose sample is analysed with respect to the predose
urine sample; this effectively serves as a control. There-
fore, unlike methods that measure the rate of appearance of
isotopes in bodily ﬂuid, this method is not affected by
short-term differences in gastric emptying or intestinal
absorption rates in relation to prior food or beverage
consumption.
To determine each dilution space and measure TBW, the
enrichment of
2H and
18O in the predose and postdose urine
samples, the dose administered, and the local tap water
were assessed via isotope ratio mass spectrometry (IRMS)
(PDZ Europa, UK).
To measure the enrichment of
2H, 0.5 ml of each urine
sample was pipetted into a 12-ml vacuutainer. A catalyst,
approximately 1 mg of platinum on alumina powder
(Sigma Aldrich) contained in a 0.5-ml vial (Hewlett
Packard Pty), was introduced into the vacuutainer while
ensuring no direct contact of the catalyst and the urine.
Each vacuutainer was evacuated for a period of 5 min
before being ﬁlled with 99% hydrogen gas. The vaccu-
tainers were then kept at room temperature for 3 days to
allow the
2H in the sample to achieve equilibrium with the
hydrogen gas [4]. All reference waters were prepared at the
same time and in the same manner as the urine samples.
Similarly, to measure the enrichment of
18O, 0.5 ml of
each urine sample were pipetted into a 12-ml vacuutainer.
The vacuutainers were then evacuated for 5 minutes, and
5% carbon dioxide, 95% nitrogen gas was introduced into
the vacuutainer. The samples were then kept at room
temperature for 24 h to facilitate the equilibrium between
the
18O in the sample and the gas. Again, reference waters
were prepared at the same time and in the same manner as
the urine samples.
The enrichment of both the
2H and
18O samples were
measured in duplicate with the results being expressed in
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water (SMOW).
The theoretical instantaneous enrichments of body
water, which could be obtained by the administered dose
and deﬁned as the intercept obtained by back-extrapolation
of the semilogarithmic plot of observed enrichment against
time, is given by a rearrangement of the equation of
Halliday and Miller [5]a s
ED ¼
TD   AD   FD
aD
EaD EtD ðÞ
1:04   TBW
for deuterium, and
EO ¼
TO   AO   FO
aO
EaO EtO ðÞ
1:01   TBW
for
18O. In these equations, A is the mass of the isotope
administered to the subject (in g), a is the mass of the dose
retained and diluted in T litres of tap water for IRMS
analysis, with the subscripts D for deuterium and O for
18O,
respectively. EaD and EaO are the enrichments of deuterium
and
18O in the dilute dose, and EtD and EtO are those of the
tap water. The factors of 1.04 and 1.01 are correction
factors to relate isotope dilution space to total body water
(TBW) [6], and are introduced to account for exchange
with sites of nonaqueous species. Finally, we have
explicitly included in this equation bioavailability factors
FD and FO. For pure water these would be taken as unity
(i.e., FO = 1); however, if it is the case that the thickening
agent reduces the degree to which water can be absorbed,
then FD would be found to be less than 1. FD can be
calculated by combining the two equations:
FD ¼ 1:035
EDaDAOTO EaO EtO ðÞ
EOaDADTD EaD EtD ðÞ
Participant
A single participant (PMMD) volunteered for the purposes
of testing. Informed consent was obtained from the
participant.
Results
The age of the subject was 25 years, height 181 cm, and
weight 64 kg. The complete set of isotope data recorded for
this subject is given in Table 1. The estimated oxygen
distribution space was 523 mg/kg, yielding an estimated
TBW of 518 ml/kg, which is in the well-documented
physiologic range. The bioavailability of water from the
thickened ﬂuid was 0.97 ± 0.06 (mean ± standard error),
suggesting that the xanthan gum ﬂuid thickener was not
binding the deuterium [i.e., water (
2H2O)] with which it
was mixed, and, therefore, the bioavailability of the water
in the solution was unaffected by the addition of the
thickening agent.
Discussion
Sharpe et al. [3] described a method to determine the
inﬂuence of thickening agents on the absorption of water.
Our short report is a ‘‘proof of concept’’ study aimed at
detailing a more accurate, less invasive approach to that
proposed by Sharpe et al. [3], involving isotopically
labeling a thickened ﬂuid to assess the bioavailability of
water when mixed with a thickening agent.
The approach discussed by Sharpe et al. [3] involved
assessing water absorption by labeling a thickened ﬂuid
with
2H and measuring the rate of appearance of
2Hi n
saliva and blood samples. In addition, the thickened ﬂuid
was also labeled with sodium bromide to determine the
extracellular water space, and bioelectrical impedance
(BIA) was used to measure TBW. While (similar to our
methods) this method involves the oral ingestion of a
labeled thickened ﬂuid and, thus, allows assessment in a
physiologically ‘‘real’’ environment, it is nevertheless
associated with several problems. First, it is difﬁcult to
ensure that residual amounts of the isotopic tracer labeling
an orally ingested ﬂuid do not remain in the mouth and,
therefore, alter the enrichment of saliva samples. While
attempts were made by the authors to minimise this
potential source of error, saliva samples are less than ideal
in these circumstances, unless alternative methods are used
to label the ﬂuid [7]. Second, this method looks at the rate
of appearance of
2H over a short time and, thus, is more
susceptible to the confounding effects of diuretics and
pretest food consumption, particularly with respect to
gastric emptying and intestinal absorption rates. Third,
while BIA is an inexpensive, noninvasive, and reliable
method of measuring TBW, it is not always accurate [8],
especially in comparison to the isotope techniques utilised
in our methodology. In addition, Sharpe et al. also
Table 1 Subject isotopic enrichment data and calculated total body water and bioavailability of water from the thickened ﬂuid (±standard error
as percentage)
ED EaD - EtD EO EaO - EtO TBW (L) from
18O FD
520.8 ± 2.1% 1028 ± 1.3% 64.0 ± 1.5% 32.8 ± 1.3% 33.66 ± 2.8% 0.97 ± 6.4%
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the saliva samples. This sample collection method is lim-
ited as it is an invasive procedure that is not well tolerated
by some individuals. Finally, adding sodium bromide to an
orally ingested ﬂuid may not be palatable because it has a
strong salty taste and thus its use may be limited in certain
populations, such as children.
We, therefore, believe our methodology to be more
accurate and less invasive than that of Sharpe et al. [3].
2H
and
18O are stable, nonradioactive, nontoxic isotopes of
hydrogen and oxygen, respectively. They are ingested in
the form of water (
2H2O and H2
18O) and, therefore, taste
similar to ordinary tap water. Samples are collected via
urine and, therefore, there are no contamination issues
related to residual amounts of tracer remaining in the oral
cavity, as with saliva samples. Urine samples are easily
collected from subjects of any age (from preterm infants to
the elderly) and, when required, may be collected via
cotton balls placed in a diaper; catheterisation is not nec-
essary due to the small volumes of urine needed (approx-
imately 2 ml). Urine samples are easy to work with for
analysis and our method is noninvasive for the subject.
Finally, stable isotope techniques are associated with good
accuracy and precision [9] and are considered the gold
standard for the measurement of TBW.
However, a limitation of our method is the relative
expense of the
18O isotope. At the time of publication, it
would cost approximately 105 $US to dose a 60-kg adult
with the amount of
18O used in our study. While
improvements in isotope ratio mass spectrometry allow
smaller and smaller dosages to be used, it is still a rela-
tively expensive way to measure TBW, compared with
either
2H or other techniques like BIA. However, while
relatively expensive, the accuracy of isotope labeling is a
major beneﬁt of this technique.
The results presented here indicate that the thickening
agent tested does not alter the apparent bioavailability of
water. Obviously, our single-subject, single-thickened-ﬂuid
example was used to describe the novel method we propose
rather than prove the effect of this thickening agent on the
bioavailability of water per se. There are many thickening
agents available on the market for patient use, and we
believe that it is important that they are all tested to
determine their impact on the bioavailability of the water in
ﬂuids with which they are mixed. Speciﬁcally, it cannot be
assumed that different thickening agents will interact in the
same way with a ﬂuid, or indeed that the same thickening
agent will interact in the same way with different ﬂuids
(e.g., water-based ﬂuids vs. nutrient-dense milk-based ﬂu-
ids) [10]. Therefore, it is essential that different combina-
tions of ﬂuids and thickening agents offered to patients are
tested to determine the bioavailability of water from dif-
ferent thickened ﬂuids. We recommend our methodology
as being both an accurate and minimally invasive way to do
so.
A further question that needs to be investigated is
whether certain individuals may be more or less effective at
digesting thickening agents and, thus, altering the avail-
ability of water from thickened ﬂuids. Interestingly, Sharpe
et al. [3] reported intersubject variation in the rate of water
uptake in their healthy, nonclinical sample group, which
may be indicative of this phenomenon. Further research
with greater numbers of participants is needed to investi-
gate this possibility. In particular, attention needs to be
given to the effect of gut pathology and/or the interference
of medication such as histamine-2 receptor antagonists and
proton pump inhibitors, on the digestion of various thick-
ening agents. This is especially so, given that many patients
are initiated on thickening agents in an attempt to manage
the symptoms of regurgitation and, therefore, will almost
certainly have some degree of gut pathology and/or be
exposed to acid suppression medications. Many dysphagic
patients who use thickened ﬂuids as a way to minimise
aspiration during swallowing may also have a coinciding
gut pathology [11].
This study detailed a novel method for investigating the
bioavailability of water when mixed with thickening
agents. Another separate but equally important issue that
merits further investigation is the bioavailability of nutri-
ents from thickened ﬂuids. Several in vitro studies have
suggested that a variable proportion of certain micronutri-
ents can become irreversibly bound to some types of
thickening agents and, thus, be rendered unavailable for
digestion [12–14]. Clearly, if conﬁrmed, this would have
implications for the use of certain thickening agents with
nutrition-providing liquids (e.g., infant formula, nutritional
supplement drinks). However, if the proportional bio-
availability of nutrients could be calculated, additional
volumes of the nutrients could be provided to allow for
some irreversible binding to the thickening agent.
Conclusion
This ‘‘proof of concept’’ study describes a novel approach
for determining the bioavailability of the water from
thickened ﬂuids, involving the measurement of the dilution
space ratios of the isotopes
2H and
18O. Using xanthan gum
as the thickening agent and a single subject, we have
shown that our method is simple, noninvasive, and accu-
rate. We recommend that further testing is required with
larger participant numbers, other thickening agents, and a
variety of ﬂuids with which thickeners are commonly
mixed. We believe that it is important that all thickening
agents recommended for patient use be tested to determine
their impact on the bioavailability of the water in the ﬂuids
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123with which they are mixed and recommend our method-
ology as currently being the most accurate and least
invasive.
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